About Rejoni
Rejoni is a company based in Bedford (United States) founded in 2020. Rejoni has raised $66.25 million across 3 funding rounds from investors including Sparta Group, Sparta Capital and CHV. Rejoni offers products and services including Juveena Hydrogel. Rejoni operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, Gameto and ClearFlow, among others.
- Headquarter Bedford, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$66.25 M (USD)
in 3 rounds
-
Latest Funding Round
$25 M (USD), Series B
Jun 16, 2026
-
Investors
Sparta Group
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rejoni
Rejoni offers a comprehensive portfolio of products and services, including Juveena Hydrogel.
Gel to prevent intrauterine adhesions after uterine surgery procedures.
People of Rejoni
Unlock access to complete
Unlock access to complete
Funding Insights of Rejoni
Rejoni has successfully raised a total of $66.25M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rejoni
Rejoni has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Sparta Group, Sparta Capital and CHV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Delos Capital is engaged in private equity and financial advisory services.
|
Locked | Locked | Locked |
Investor details for Rejoni
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rejoni
Investment portfolio details for Rejoni
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rejoni
Detailed financials for Rejoni
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rejoni Comparisons
Peer comparison for Rejoni
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rejoni
Rejoni operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, Gameto and ClearFlow, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for fertility and menopause treatments are developed.
|
|
| Locked | Locked | Locked |
Anti-clogging technologies for medical drainage catheters are developed.
|
Detailed competitors of Rejoni
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rejoni
Complete news archive for Rejoni
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rejoni
Rejoni was founded in 2020.
Rejoni is headquartered in Bedford, United States.
Rejoni is a funded company, having raised a total of $66.25M across 3 funding rounds to date.
Rejoni was founded in 2020 and is based in Bedford, United States. Focus is placed on the biotechnology sector, where therapeutics for womens health conditions are developed. Operations center on creating a soft gel-like material named Juveena Hydrogel, which is designed to prevent intrauterine adhesions after uterine surgery. This approach addresses post-surgical complications in gynecological care through targeted medical interventions.
Rejoni's top competitors include Sprout Pharmaceuticals, Hope Medicine and Gameto.
Rejoni offers Juveena Hydrogel.
Rejoni has 10 investors. Key investors include Sparta Group, Sparta Capital, CHV, Ascension Ventures, and Delos Capital.